Sex/gender Differences in Cardiovascular Disease Prevention: What a Difference a Decade Makes

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2011 Nov 9

PMID 22064958

Citations 416

Authors

Lori Mosca

Elizabeth Barrett-Connor

Nanette Kass Wenger

Affiliations

Soon will be listed here.

Citing Articles

Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis.

Asztalos B, Russo G, He L, Diffenderfer M Nutrients. 2025; 17(5).

PMID: 40077610 PMC: 11902009. DOI: 10.3390/nu17050740.

The hidden interplay between sex and adverse outcomes in incident dialysis patients: the role of aortic calcification.

Zhao X, Lei Z, Wang M, Liu H, Yan M, Huo L Clin Kidney J. 2025; 18(3):sfaf034.

PMID: 40052162 PMC: 11883226. DOI: 10.1093/ckj/sfaf034.

Studying gender in the experiences of patients with heart failure: A scoping review of qualitative studies and methodological recommendations.

Thomas E, Verdonk P, Roeters-van Lennep J, Rhodius-Meester H, Handoko L, Schoonmade L Womens Health (Lond). 2025; 21:17455057241305078.

PMID: 39883432 PMC: 11783506. DOI: 10.1177/17455057241305078.

Obesity-induced mesenteric PVAT remodelling is sexually dimorphic, but not driven by ovarian hormones : Short title: Obesity induces sex-specific responses in mesenteric PVAT.

Ivatt L, Paul M, Miguelez-Crespo A, Hadoke P, Bailey M, Morgan R Cardiovasc Diabetol. 2025; 24(1):39.

PMID: 39856754 PMC: 11762466. DOI: 10.1186/s12933-025-02596-w.

Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis.

Akhtar M, Farooqi H, Nabi R, Abbasi S, MaCKenzie Picker S, Ahmed R Clin Cardiol. 2025; 48(1):e70079.

PMID: 39817587 PMC: 11736633. DOI: 10.1002/clc.70079.

References

Melloni C, Berger J, Wang T, Gunes F, Stebbins A, Pieper K . Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010; 3(2):135-42. DOI: 10.1161/CIRCOUTCOMES.110.868307. View

Cabana M, Rand C, Powe N, Wu A, Wilson M, Abboud P . Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282(15):1458-65. DOI: 10.1001/jama.282.15.1458. View

Vaccarino V, Parsons L, Peterson E, Rogers W, Kiefe C, Canto J . Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med. 2009; 169(19):1767-74. PMC: 3113508. DOI: 10.1001/archinternmed.2009.332. View

Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T . Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study). Circulation. 2008; 117(4):494-502. DOI: 10.1161/CIRCULATIONAHA.106.671826. View

Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R . Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-60. PMC: 2715005. DOI: 10.1016/S0140-6736(09)60503-1. View

Albert C, Cook N, Gaziano J, Zaharris E, MacFadyen J, Danielson E . Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008; 299(17):2027-36. PMC: 2684623. DOI: 10.1001/jama.299.17.2027. View

Jamison R, Hartigan P, Kaufman J, Goldfarb D, Warren S, Guarino P . Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007; 298(10):1163-70. DOI: 10.1001/jama.298.10.1163. View

Mosca L, Linfante A, Benjamin E, Berra K, Hayes S, Walsh B . National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005; 111(4):499-510. DOI: 10.1161/01.CIR.0000154568.43333.82. View

Ford E, Ajani U, Croft J, Critchley J, Labarthe D, Kottke T . Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23):2388-98. DOI: 10.1056/NEJMsa053935. View

10.

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

11.

Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson B . Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke. 2008; 40(1):147-55. PMC: 3559135. DOI: 10.1161/STROKEAHA.108.518621. View

12.

Aldea G, Gaudiani J, Shapira O, Jacobs A, Weinberg J, Cupples A . Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting. Ann Thorac Surg. 1999; 67(4):1097-103. DOI: 10.1016/s0003-4975(99)00055-7. View

13.

Dhruva S, Bero L, Redberg R . Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circ Cardiovasc Qual Outcomes. 2011; 4(2):165-71. DOI: 10.1161/CIRCOUTCOMES.110.958215. View

14.

Berger J, Elliott L, Gallup D, Roe M, Granger C, Armstrong P . Sex differences in mortality following acute coronary syndromes. JAMA. 2009; 302(8):874-82. PMC: 2778841. DOI: 10.1001/jama.2009.1227. View

15.

Barrett-Connor E, Mosca L, Collins P, Geiger M, Grady D, Kornitzer M . Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006; 355(2):125-37. DOI: 10.1056/NEJMoa062462. View

16.

Cowie C, Rust K, Ford E, Eberhardt M, Byrd-Holt D, Li C . Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2008; 32(2):287-94. PMC: 2628695. DOI: 10.2337/dc08-1296. View

17.

Lonn E, Yusuf S, Arnold M, Sheridan P, Pogue J, Micks M . Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006; 354(15):1567-77. DOI: 10.1056/NEJMoa060900. View

18.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

19.

Ridker P, Danielson E, Fonseca F, Genest J, Gotto Jr A, Kastelein J . Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359(21):2195-207. DOI: 10.1056/NEJMoa0807646. View

20.

Vaccarino V, Parsons L, Every N, Barron H, Krumholz H . Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999; 341(4):217-25. DOI: 10.1056/NEJM199907223410401. View